Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
A2 Biotherapeutics Inc.
National Institutes of Health Clinical Center (CC)
A2 Biotherapeutics Inc.
St. Jude Children's Research Hospital
University of Nebraska
Takeda
VM Oncology, LLC
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Actym Therapeutics, Inc.
Travera Inc
TCR2 Therapeutics
Azienda Ospedaliera di Padova
A2 Biotherapeutics Inc.
University of Pittsburgh
Azienda USL Reggio Emilia - IRCCS
Cancer Research UK
Alliance for Clinical Trials in Oncology
BerGenBio ASA
Sheffield Teaching Hospitals NHS Foundation Trust
Travera Inc
NGM Biopharmaceuticals, Inc
UTC Therapeutics Inc.
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
NGM Biopharmaceuticals, Inc
Massachusetts General Hospital
Quadriga Biosciences, Inc.
MacroGenics
Abramson Cancer Center at Penn Medicine
Shenzhen BinDeBio Ltd.
National Institutes of Health Clinical Center (CC)
University of Magdeburg
National Institutes of Health Clinical Center (CC)
Swiss Cancer Institute
NHS Greater Glasgow and Clyde
Masonic Cancer Center, University of Minnesota
Stanford University
Chinese PLA General Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Morphotek
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center